mutant. Information for all plasmids and strains used in the study is shown in Supplemental Table 1. 
MunI and XhoI and the amplified downstream fragment was also digested with XhoI and SmaI. pCTF89 was digested with EcoRI and SmaI and ligated with the upstream and downstream fragments, resulting in pCTF101.
A markerless deletion of fhuBG was performed as described previously. 7 The theory of markerless deletion is described by Szurmant et al. 21 TC129 (wild-type) was transferred with non-methylated pCTF101 and the transformants were then incubated at 30 ˚C on a LB plate containing 1 μg/mL erythromycin. The obtained transformants containing the pCTF101 plasmid were incubated at 42 ˚C in LB medium containing 1 μg/mL erythromycin to integrate the plasmid in the chromosome, resulting in TC133. The created strain, TC133 (fhuBG::erm), was transformed with non-methylated pBKJ223 and the transformants were incubated at 37 ˚C with 10 μg/mL tetracycline. The constructed strain, TC136, tetracycline-resistant, erythromycin-sensitive and the fhuBG genes deleted, was selected and then incubated in LB medium without any antibiotics at 37 ˚C five times to eliminate pBKJ223 plasmid from TC136, resulting in TC137. TC137 is a tetracycline-sensitive and erythromycin-sensitive strain and it is confirmed by PCR that the fhuBG genes are eliminated. 
Supplemental figure legends

